Author: Fiona Craig

Blackbird plc (LSE:BIRD) has announced that its annual general meeting will take place at 11:00 a.m. on 10 June 2026 at the London offices of Blake Morgan.

The company said it held more than £2.4 million in cash and short-term deposits at the end of April 2026 and currently has no plans to raise additional capital. Management stated that existing cash resources are expected to fund the commercial rollout of its elevate.io platform.

elevate.io Moves Into Go-to-Market Phase

Blackbird plc said elevate.io is now transitioning from the product-market-fit stage into a broader go-to-market strategy. The platform is being targeted at corporate marketing teams, with a focus on addressing challenges such as multi-stakeholder video review processes, workflow management, and scaling video production output.

The company plans to present its commercial strategy for elevate.io following the formal AGM proceedings, with shareholders invited to engage directly with management and members of the marketing team.

AGM Participation and Shareholder Arrangements

Shareholders who opted for printed communications will receive AGM documentation, including the notice of meeting, by post. The materials will also be available through the company’s website. Annual reports and accounts for the year ended 31 December 2025 are likewise being distributed to shareholders who requested physical copies.

The AGM will be accessible both in person and online through the Investor Meet Company platform. However, voting will only be possible via proxy submission through MUFG Corporate Markets or by returning a physical proxy form at least two business days before the meeting.

More About Blackbird plc

Blackbird plc develops cloud-native video editing and collaborative content production platforms. Its products include elevate.io, a browser-based collaborative video editor, and the Blackbird cloud video editing platform.

The company also licenses its proprietary video technology to third-party businesses operating in media, production, and digital content markets.

FRP Advisory Group Plc (LSE:FRP) said it expects full-year revenue for the year ended 30 April 2026 to rise 16% to at least £176 million, while adjusted underlying EBITDA is projected to increase 9% to a minimum of £45 million. The results are broadly in line with market expectations despite ongoing macroeconomic uncertainty.

Growth during the period was driven by strong demand for the group’s restructuring services, record revenues within its corporate finance division, and continued activity across financial advisory and forensic services. The company said its corporate finance business particularly benefited from resilient lower mid-market transactions and ongoing private equity activity. Headcount increased 12% year-on-year to 894 employees, and the board intends to propose a final dividend.

Expansion Strategy and Acquisition Activity Continue

FRP Advisory Group Plc maintained a strong financial position with approximately £26 million in net cash at year end, supported by an undrawn £10 million revolving credit facility.

The company continues to pursue a combined organic growth and acquisition strategy, including the acquisitions of One Advisory and Arc & Co, as well as a minority investment in Queens Tower Advisory. FRP also expanded its office and service network across Liverpool, Leeds, Manchester, and London while formally launching a new Real Estate Advisory division.

Management said the group is well positioned to benefit from increased restructuring and debt advisory demand amid persistent inflation, elevated energy costs, and ongoing supply chain disruption, supporting confidence in continued growth through FY2027 and beyond.

Financial Position and Market Outlook

The company’s outlook continues to be supported by strong underlying financial performance, strategic expansion initiatives, and positive market positioning. Recent acquisitions and geographic expansion have reinforced FRP’s growth profile, while technical indicators continue to suggest positive market momentum.

Valuation metrics remain relatively balanced, reflecting both the company’s growth prospects and its income-generating characteristics. The absence of recent earnings call commentary was not viewed as materially affecting the overall outlook.

More About FRP Advisory Group Plc

FRP Advisory Group Plc is a UK-based specialist advisory firm established in 2010 that provides restructuring, corporate finance, debt advisory, forensic, and financial advisory services to businesses, lenders, investors, and individuals.

The company operates across the economic cycle, with particular strength in UK insolvency work, lower mid-market mergers and acquisitions, and debt advisory services. FRP continues to expand both geographically and across new service areas, including its recently launched Real Estate Advisory platform.

Predator Oil & Gas Holdings Plc (LSE:PRD) has raised £3 million through a placing of 85.7 million new shares at 3.5 pence each to support an expanded operational programme across its assets in Trinidad, Morocco, and Ireland. The company also reported that April production revenues from Trinidad exceeded internal forecasts by 26%.

The funding will support the deepening of the Snowcap-3 well, the reactivation of the Snowcap-2ST1 and Jacobin-1 wells, and feasibility studies relating to gas re-injection and gas-to-power initiatives in Trinidad. In Morocco, proceeds will help secure long-lead equipment and engineering work for the MOU-6 well alongside pilot compressed natural gas (CNG) development activities.

Focus on Corrib South and European Gas Opportunities

Predator Oil & Gas Holdings Plc also plans to advance an updated technical package and continue its search for partners for the Corrib South gas prospect offshore Ireland. Management said the asset could play an important role in supporting European energy security.

The company added that recent regulatory developments together with updated resource and economic assessments have strengthened the case for bringing Corrib South back into active development planning. Predator aims to use its positions in Morocco and Atlantic Ireland to attract industry partners seeking access to gas resources connected to European markets.

Additional Use of Proceeds and Financial Outlook

The fundraising proceeds will additionally cover environmental studies, legal and administrative expenses, and potential strategic investments in infrastructure projects. The placing also includes the issue of new warrants alongside an enlarged share capital base.

Despite stronger revenue performance and a relatively low-debt balance sheet, the company’s outlook continues to be constrained by weak financial fundamentals, including sizeable losses, negative profit margins, and ongoing cash burn. Technical indicators remain broadly neutral with modest trend support, while valuation metrics continue to be challenged by the company’s negative price-to-earnings ratio and lack of dividend yield data.

More About Predator Oil & Gas Holdings Plc

Predator Oil & Gas Holdings Plc is a Jersey-based oil and gas business with producing hydrocarbon operations in Trinidad and Morocco as well as prospective offshore gas assets in Ireland.

The company focuses on onshore and offshore gas and oil opportunities located close to European gas infrastructure, aiming to benefit from evolving regional energy security priorities and natural gas supply dynamics.

Forgent plc (LSE:FORG) has announced the full and final settlement of a legacy legal dispute connected to the North Fork project, where the company had been named as a joint defendant alongside several other parties, including director David Palumbo.

The case, which was brought in California by former tax-credit investor SCV North Fork LLC, was resolved through mediation. The settlement was completed without any admission of liability or wrongdoing by any of the parties involved.

Settlement Clears Path for Strategic Focus

Management said resolving the dispute removes a longstanding source of uncertainty for the business and allows the company to focus fully on implementing its strategy within the energy transition sector.

Forgent plc added that the conclusion of the case simplifies its legal position and may help improve investor confidence by eliminating a historic issue associated with the North Fork project.

Financial and Market Outlook

The company’s outlook continues to be weighed down by weak financial fundamentals, including ongoing losses, leverage exposure, and persistently negative cash flow.

Technical indicators also remain weak, reflecting a sustained downward share price trend. Valuation metrics provide limited support due to the company’s negative price-to-earnings ratio and the absence of dividend yield data.

More About Forgent plc

Forgent plc is an AIM-listed business focused on technologies and projects linked to the global energy transition.

The company develops and operates initiatives aimed at supporting cleaner and more sustainable energy systems, positioning itself within the wider decarbonisation and clean energy infrastructure sector.

TT Electronics (LSE:TTG) reported that group revenue for the four months ended 30 April 2026 declined 4.8% on an organic basis, mainly due to weaker demand across its electronics manufacturing services (EMS) markets. However, excluding the transfer of a major EMS customer and the closure of the Plano facility, underlying organic revenue increased 2.9%.

The company said a strong book-to-bill ratio of 107%, supported largely by aerospace and defence demand, together with ongoing cost-saving initiatives and sales transformation efforts, continues to support guidance for adjusted operating profit in line with market expectations.

Cost Savings and Organisational Changes Progressing

Management confirmed that the company’s transition to a revised divisional structure has now been completed. TT Electronics also said its cost reduction programme remains on track to deliver a net £3 million benefit during the current financial year.

The company added that investments aimed at transforming its sales operations are beginning to generate positive results. In parallel, the board continues to assess strategic options for the Components division as part of its broader portfolio review.

Ian Ashton is scheduled to join the company as chief financial officer on 29 June 2026. Interim finance chief Richard Webb will remain in place during the transition process to support an orderly handover ahead of interim results expected on 2 September 2026.

Financial Position and Market Outlook

TT Electronics continues to show mixed financial characteristics. Strong recent cash generation and a meaningful reduction in debt levels have partly offset longer-term revenue declines and continuing net losses.

Management commentary supporting in-line guidance, improving margins, and stronger cash conversion has provided some support to sentiment. However, weak technical indicators and a negative price-to-earnings ratio continue to weigh on the company’s broader market outlook.

More About TT Electronics

TT Electronics is a global designer and manufacturer of engineered electronic solutions used in performance-critical applications.

The company serves growth markets including healthcare, aerospace, defence, industrial automation, and electrification. Its product portfolio includes sensors, power management technologies, and connectivity solutions manufactured through facilities across the UK, North America, and Asia.

ValiRx plc (LSE:VAL) has launched a fundraising initiative of up to £1.155 million through a discounted placing, a director subscription, and a planned retail offer. The transaction involves the proposed issue of up to 502.5 million new shares priced at 0.2 pence each, with every new share carrying one three-year warrant, subject to shareholder approval.

The fundraising will also include broker warrants for Shard Capital and an enlarged AIM-listed share capital. Management said the proceeds are intended to fund in-licensing opportunities, intellectual property expansion, preclinical development work, and the continued growth of the company’s companion animal health business.

Focus on Development Milestones and Partnerships

ValiRx plc said the capital raise is designed to support several upcoming value-driving milestones, including patent development linked to Cytolytix, advancement of the VAL201 2.0 programme, progress on the McGill asset SPV, and applications for non-dilutive funding.

Management believes the financing strengthens a portfolio of oncology, women’s health, and animal health assets that it considers undervalued. The company said the structure of the fundraising — including identical pricing for retail investors and attached warrant coverage — is intended to broaden investor participation despite the dilution associated with the share issue.

The company continues to pursue a strategy centred on licensing arrangements, special purpose vehicles, and grant funding in an effort to reduce reliance on the traditionally high-cost biotech development model.

Financial and Market Outlook

The company’s outlook remains heavily influenced by weak financial performance, including ongoing losses and continued dependence on external financing.

Technical indicators currently suggest a bearish trading trend, although some signals point to the possibility of short-term upward movement. Valuation metrics remain unattractive due to the company’s negative price-to-earnings ratio and the absence of dividend support.

More About ValiRx plc

ValiRx plc is a London-listed biotechnology and life sciences company focused on early-stage cancer therapeutics and women’s health programmes, including assets such as CLX001 and VAL201.

Through subsidiaries including Inaphaea Biolabs and the developing ValiRx Animal Health division, the company seeks to advance academic and early-stage scientific innovations into preclinical development while expanding its intellectual property portfolio through a capital-efficient, partnership-led approach.

Kendrick Resources PLC (LSE:KEN) has announced new drilling and surface sampling results from its Teufelskuppe rare earth project in Namibia, highlighting high-grade mineralisation across multiple carbonatite bodies both at surface and at depth.

An internal estimate indicates the presence of approximately 14 million tonnes of above-ground material grading an average 3.12% total rare earth oxides (TREO), with some zones returning grades of up to 4.79% TREO. The latest TK2 diamond drill hole intersected an average grade of 3.03% TREO across 112 metres, including higher-grade intervals exceeding 4%.

Resource Development and Processing Potential

Management said the latest results, combined with favourable mineralogy dominated by rare earth fluorcarbonates, strengthen the company’s view that Teufelskuppe could develop into a large-scale and potentially high-ranking rare earth project. The company added that the mineralisation appears suitable for conventional processing methods.

Kendrick Resources PLC is now accelerating work programmes aimed at delivering maiden JORC-compliant mineral resource estimates for both the TK and KH projects. Planned activities include expanded drilling campaigns, metallurgical testing, logistics studies, and preliminary economic assessments as the company advances toward a possible future mine development decision.

Financial Position and Market Outlook

The company’s outlook remains constrained by weak financial fundamentals, including a lack of revenue generation, recurring losses, and continued negative cash flow. Kendrick’s balance sheet also weakened significantly during 2025, with declining asset values and negative equity adding further financial pressure.

Technical indicators remain supportive in the near term due to strong upward momentum in the share price. However, heavily overbought conditions suggest an increased risk of market pullbacks. Valuation metrics remain limited by the company’s loss-making position and the absence of dividend yield data.

More About Kendrick Resources PLC

Kendrick Resources PLC is a mineral exploration and development company focused on rare earth element projects, particularly the Teufelskuppe (TK) and Kieshöhe (KH) carbonatite complexes in Namibia.

Through a 70% earn-in arrangement with Bonya Exploration, the company is targeting high-grade deposits containing strategic rare earth elements such as neodymium and praseodymium, which are widely used in advanced technologies and clean energy applications.

Volvere plc (LSE:VLE) delivered solid results for the 2025 financial year, with continuing operations revenue — entirely generated by Shire Foods — increasing 7.5% to £52.70 million. Profit before tax rose slightly to £6.75 million, while group profit after tax improved to £5.11 million.

The company also reported growth in net assets to £47.20 million, with net asset value per share climbing to £19.80. Cash and liquid investments totalled £33.22 million at year end, reinforcing the group’s strong liquidity position.

Rising Costs Expected to Pressure 2026 Margins

Management warned that trading conditions at Shire Foods during 2026 are being affected by higher labour, raw material, and distribution expenses. In addition, volumes from a major customer focused on “value” product ranges have declined following product range rationalisation.

The company said these factors are expected to place pressure on margins and profitability, particularly during the first half of 2026. Despite this, Volvere continues to execute share buybacks and remains focused on strengthening long-term customer relationships, supporting brand development, and identifying further investment opportunities within the food industry and related sectors.

Strong Balance Sheet Supports Long-Term Flexibility

Over the past five years, Shire Foods has delivered consistent revenue growth and improving profitability despite difficult economic conditions. Management said the combination of rising asset value, substantial liquidity, and a disciplined investment strategy positions Volvere to navigate near-term operational pressures while maintaining flexibility for future acquisitions.

The company’s outlook is supported by strong financial performance, positive technical indicators, and effective cash management. While valuation metrics remain relatively reasonable, management acknowledged that the absence of a dividend yield and indications of potentially overbought trading conditions may temper sentiment. Recent share repurchases also continue to support shareholder returns.

More About Volvere

Volvere plc is a UK-based investment company specialising in acquiring and managing undervalued, distressed, or complementary businesses. Its primary operating asset is Shire Foods, which manufactures value and premium food products for retail and foodservice customers while focusing on operational improvement and long-term commercial partnerships.

The group acts as a holding company, providing management expertise and capital support to its portfolio businesses while maintaining a strong liquidity position to pursue additional investments in food manufacturing and adjacent industries. Since its acquisition in 2011, Shire Foods has evolved from a small loss-making business into a significantly larger and consistently profitable operation within the group.

Bluebird Mining Ventures (LSE:BMV) has generated its first operating revenues following the launch of its Bitcoin and precious-metals-linked streaming activities in April 2026, marking a significant milestone in the company’s transition toward cash-generating assets.

The company said the estimated value of its streaming and operating asset portfolio has reached approximately US$508,870, driven primarily by Bitcoin streaming arrangements and hashrate contracts. Management added that it is targeting portfolio returns exceeding 20%.

Shift Toward Lower-Risk Streaming Opportunities

Management said the company is repositioning its gold streaming strategy toward lower-risk opportunities supported by existing production and cash flow, while moving away from higher-risk development projects such as the Crawford Gold Project in its original structure.

At the same time, Bluebird has established a treasury valued at around US$0.8 million, consisting mainly of tokenised and physical gold holdings together with Bitcoin assets. The company said combined estimated net asset value now stands at approximately US$1.3 million, representing an 885% year-on-year increase in aggregate NAV per share.

Bitcoin Mining Partnership With Cascadia

Bluebird Mining Ventures has also entered into a term sheet agreement with Cascadia Industries to deploy around 750 inactive Bitcoin mining units under a zero-capex and zero-opex arrangement.

Under the agreement, Cascadia will provide hosting infrastructure and operational support, while net Bitcoin production is expected to be transferred directly into Bluebird’s digital wallets within six months. The company said the structure provides low-risk exposure to digital asset production and supports its broader strategy of compounding shareholder value through streaming economics and treasury growth.

Financial and Market Outlook

The company’s outlook continues to be constrained by weak financial fundamentals, including a lack of meaningful historical revenue, continuing operating losses, and persistently negative cash flow. Balance-sheet leverage metrics provide some limited support, but overall financial performance remains under pressure.

Technical indicators also remain weak, with the stock trading below major moving averages and momentum indicators such as MACD remaining negative. Valuation metrics continue to be negatively affected by the company’s loss-making status and the absence of dividend yield data.

More About Bluebird Merchant Ventures

Bluebird Mining Ventures is a London-listed mining, streaming, and treasury business focused on building a gold-backed treasury model through streaming agreements tied to precious metals production.

The company targets exposure across the ore concentrate-to-bullion value chain, seeking scalable access to physical gold and related hard assets while minimising the capital expenditure and operational risks typically associated with traditional mining development.

Physiomics plc (LSE:PYC) has confirmed that chief executive Peter Sargent will remain in his position through June 2026 after agreeing to extend his current contract. The move is intended to provide operational continuity as the company progresses through a period of internal transition and strategic development.

The board said discussions are continuing regarding a potential longer-term role for Sargent, reflecting his importance to the business and his involvement in supporting management changes while the company develops future growth and expansion plans.

Leadership Stability Supports Strategic Development

Chairman Nick Tulloch praised Sargent’s management of day-to-day operations and his role in overseeing leadership transitions within the business. According to the board, his continued leadership is expected to assist the recently restructured board as it refines the company’s strategic direction.

The announcement is seen as reinforcing leadership stability at a time when consistent operational execution is likely to be important for Physiomics as it competes within the growing market for model-informed drug development services.

Financial and Market Outlook

Physiomics plc continues to face pressure from weak underlying financial performance, with ongoing losses and sustained cash burn outweighing the benefits of a low-debt balance sheet and a recovery in revenue during 2025.

Technical indicators are moderately positive, with the share price trading above major moving averages and momentum indicators such as MACD remaining supportive. However, an elevated RSI suggests recent momentum may be becoming overstretched. Valuation metrics remain relatively weak due to negative earnings and the lack of dividend support.

More About Physiomics

Physiomics plc is a UK-listed specialist in mathematical modelling, biostatistics, and data science focused on supporting drug development and personalised medicine programmes.

The company combines expertise in modelling and simulation, bioinformatics, and systems biology, using proprietary technologies including its Virtual Tumour platform to help streamline therapeutic development for biotechnology and pharmaceutical clients such as Merck KGaA, Astellas Pharma, and Cancer Research UK.